WC
Wexford Capital Portfolio holdings
AUM
$359M
1-Year Return
31.38%
This Quarter Return
+6.81%
1 Year Return
+31.38%
3 Year Return
+167.75%
5 Year Return
–
10 Year Return
–
AUM
$466M
AUM Growth
+$25.4M
(+5.8%)
Cap. Flow
+$16.2M
Cap. Flow
% of AUM
3.47%
Top 10 Holdings %
Top 10 Hldgs %
40.95%
Holding
300
New
120
Increased
34
Reduced
45
Closed
85
Top Buys
| 1 |
iShares MSCI Australia ETF
EWA
|
$9.97M |
| 2 |
iShares MSCI Canada ETF
EWC
|
$9.96M |
| 3 |
SPDR Portfolio S&P 600 Small Cap ETF
SPSM
|
$9.91M |
| 4 |
SBOW
SilverBow Resources, Inc.
SBOW
|
$8.2M |
| 5 |
International Seaways
INSW
|
$6.98M |
Top Sells
| 1 |
Canadian Natural Resources
CNQ
|
$15.5M |
| 2 |
Rogers Communications
RCI
|
$9.9M |
| 3 |
Imperial Oil
IMO
|
$6.81M |
| 4 |
Stellantis
STLA
|
$6.7M |
| 5 |
CD
Chindata Group Holdings Limited American Depositary Shares
CD
|
$6.64M |
Sector Composition
| 1 | Industrials | 23.84% |
| 2 | Energy | 18.88% |
| 3 | Utilities | 8.41% |
| 4 | Healthcare | 7.4% |
| 5 | Consumer Staples | 4.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
FSR
176
DELISTED
Fisker Inc.
FSR
| $24.5K | 0.01% |
+13,990
| New | +$24.5K |
|
|
TWOU
177
DELISTED
2U, Inc.
TWOU
| $24.4K | 0.01% |
+660
| New | +$24.4K |
|
178
Fossil Group
FOSL
$165M
| $24K | 0.01% |
+16,460
| New | +$24K |
|
179
System1
SST
$62.5M
| $23.9K | 0.01% |
+1,075
| New | +$23.9K |
|
|
NVTA
180
DELISTED
Invitae Corporation
NVTA
| $23.7K | 0.01% |
+37,880
| New | +$23.7K |
|
181
Karyopharm Therapeutics
KPTI
$57.2M
| $23.6K | 0.01% |
+1,819
| New | +$23.6K |
|
182
Seer Inc
SEER
$118M
| $23K | ﹤0.01% |
+11,870
| New | +$23K |
|
183
Vor Biopharma
VOR
$248M
| $22.6K | ﹤0.01% |
+10,050
| New | +$22.6K |
|
184
ProKidney
PROK
$304M
| $22.4K | ﹤0.01% |
+12,580
| New | +$22.4K |
|
185
Kezar Life Sciences
KZR
$29.8M
| $22.1K | ﹤0.01% |
+2,332
| New | +$22.1K |
|
|
OCEA
186
DELISTED
Ocean Biomedical, Inc. Common Stock
OCEA
| $22K | ﹤0.01% |
+33,310
| New | +$22K |
|
187
Erasca
ERAS
$457M
| $21.9K | ﹤0.01% |
+10,290
| New | +$21.9K |
|
|
AEVA
188
Aeva Technologies
AEVA
$786M
| $21.6K | ﹤0.01% |
+5,706
| New | +$21.6K |
|
|
ME
189
DELISTED
23andMe Holding Co. Class A Common Stock
ME
| $21.3K | ﹤0.01% |
+1,169
| New | +$21.3K |
|
190
Nuvation Bio
NUVB
$1.33B
| $21.1K | ﹤0.01% |
13,997
-25,105
| -64% | -$37.9K |
|
191
Aclaris Therapeutics
ACRS
$227M
| $21K | ﹤0.01% |
+20,000
| New | +$21K |
|
192
Origin Materials
ORGN
$77.7M
| $21K | ﹤0.01% |
+25,110
| New | +$21K |
|
193
FiscalNote
NOTE
$58.7M
| $20.8K | ﹤0.01% |
+1,522
| New | +$20.8K |
|
194
Assertio
ASRT
$76.8M
| $20.6K | ﹤0.01% |
+19,230
| New | +$20.6K |
|
|
AGEN
195
Agenus
AGEN
$138M
| $20.6K | ﹤0.01% |
+1,242
| New | +$20.6K |
|
196
Purple Innovation
PRPL
$122M
| $19.9K | ﹤0.01% |
+19,320
| New | +$19.9K |
|
197
5E Advanced Materials
FEAM
$77.2M
| $19.9K | ﹤0.01% |
+612
| New | +$19.9K |
|
198
Compass Therapeutics
CMPX
$590M
| $19.8K | ﹤0.01% |
+12,700
| New | +$19.8K |
|
199
Workhorse Group
WKHS
$19.4M
| $19.4K | ﹤0.01% |
+216
| New | +$19.4K |
|
200
Outlook Therapeutics
OTLK
$41.5M
| $19.2K | ﹤0.01% |
+2,435
| New | +$19.2K |
|